These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19347882)

  • 21. Epidermal growth factor receptor expression in invasive thymoma.
    Henley JD; Koukoulis GK; Loehrer PJ
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
    Kobayashi H; Ishii Y; Takayama T
    J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
    Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Type Amino Acid Transporter 1 Immunoreactivity as a Possible Diagnostic and Prognostic Marker of Thymic Carcinoma.
    Maeda S; Nakazato Y; Hayashi K; Nishihira M; Inoue T; Araki O; Karube Y; Kobayashi S; Chida M
    Tohoku J Exp Med; 2018 Nov; 246(3):167-174. PubMed ID: 30449824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus.
    Cimpean AM; Raica M; Encica S; Cornea R; Bocan V
    Ann Anat; 2008; 190(3):238-45. PubMed ID: 18356031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
    Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
    Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas.
    Sadohara J; Fujimoto K; Müller NL; Kato S; Takamori S; Ohkuma K; Terasaki H; Hayabuchi N
    Eur J Radiol; 2006 Oct; 60(1):70-9. PubMed ID: 16766154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression].
    Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N
    Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
    Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
    Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
    Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
    Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An institutional study on thymomas and thymic carcinomas: experience in 77 patients.
    Rieker RJ; Muley T; Klein C; Schnabel PA; Herpel E; Meister M; Schirmacher P; Dienemann H; Pfannschmidt J
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):143-7. PubMed ID: 18365972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC; Chen PC; Chou TY; Chiang H
    Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.
    Pan CC; Chen PC; Chiang H
    J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.
    Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
    Am J Pathol; 1988 Dec; 133(3):615-22. PubMed ID: 3202120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors.
    Tomita M; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
    J Thorac Cardiovasc Surg; 2002 Sep; 124(3):493-8. PubMed ID: 12202865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
    Roden AC; Yi ES; Jenkins SM; Donovan JL; Cassivi SD; Garces YI; Marks RS; Aubry MC
    Hum Pathol; 2015 Jan; 46(1):17-25. PubMed ID: 25455993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.